Skip to main content
Erschienen in: Diabetologia 7/2012

01.07.2012 | Short Communication

Exercise-induced albuminuria is associated with perivascular renal sinus fat in individuals at increased risk of type 2 diabetes

verfasst von: R. Wagner, J. Machann, R. Lehmann, K. Rittig, F. Schick, J. Lenhart, F. Artunc, K. Linder, C. D. Claussen, E. Schleicher, A. Fritsche, H.-U. Häring, P. Weyrich

Erschienen in: Diabetologia | Ausgabe 7/2012

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Microalbuminuria represents an established surrogate marker of early diabetic nephropathy and glomerular microangiopathy. Increasing evidence is emerging of a role of perivascular adipose tissue (PVAT) as an important link between obesity, insulin resistance and both macro- and microangiopathy. It is not known whether perivascular renal sinus fat (RSF) has an impact on microalbuminuria in the prediabetic stage. We investigated whether RSF quantified by MRI is associated with microalbuminuria before or after exercise.

Methods

Non-diabetic individuals at increased risk of type 2 diabetes were recruited into the Tübingen Lifestyle Intervention Program (TULIP); 146 participants took part in the analysis. RSF was measured in axial MRI sections at the level of the renal artery. Urine was collected before and after exercise stress testing.

Results

Participants (age 47 ± 12 years; mean ± SD) reached a mean exercise load of 176 ± 49 W, with a mean arterial peak pressure (MAPP) of 112 ± 14 mmHg. After adjusting for sex, age, visceral adipose tissue (VAT) and MAPP during exercise, RSF was significantly associated with postexercise albumin/creatinine ratio (ACR; p = 0.006). No association between RSF and baseline BP could be observed after adjusting for confounders (p = 0.26), and there was no association between RSF and baseline ACR either (p = 0.2).

Conclusions

RSF is associated with exercise-induced albuminuria independently of sex, age, VAT and MAPP in a non-diabetic cohort at diabetic risk. We conclude that PVAT in the renal sinus may play a role in the pathogenesis of microalbuminuria.
Literatur
1.
Zurück zum Zitat Stefan N, Häring H-U (2011) The metabolically benign and malignant fatty liver. Diabetes 60:2011–2017PubMedCrossRef Stefan N, Häring H-U (2011) The metabolically benign and malignant fatty liver. Diabetes 60:2011–2017PubMedCrossRef
2.
Zurück zum Zitat Rittig K, Staib K, Machann J et al (2008) Perivascular fatty tissue at the brachial artery is linked to insulin resistance but not to local endothelial dysfunction. Diabetologia 51:2093–2099PubMedCrossRef Rittig K, Staib K, Machann J et al (2008) Perivascular fatty tissue at the brachial artery is linked to insulin resistance but not to local endothelial dysfunction. Diabetologia 51:2093–2099PubMedCrossRef
3.
Zurück zum Zitat Meijer RI, Serne EH, Smulders YM, van Hinsbergh VWM, Yudkin JS, Eringa EC (2011) Perivascular adipose tissue and its role in type 2 diabetes and cardiovascular disease. Curr Diab Rep 11:211–217PubMedCrossRef Meijer RI, Serne EH, Smulders YM, van Hinsbergh VWM, Yudkin JS, Eringa EC (2011) Perivascular adipose tissue and its role in type 2 diabetes and cardiovascular disease. Curr Diab Rep 11:211–217PubMedCrossRef
4.
Zurück zum Zitat Chughtai HL, Morgan TM, Rocco M et al (2010) Renal sinus fat and poor BP control in middle-aged and elderly individuals at risk for cardiovascular events. Hypertension 56:901–906PubMedCrossRef Chughtai HL, Morgan TM, Rocco M et al (2010) Renal sinus fat and poor BP control in middle-aged and elderly individuals at risk for cardiovascular events. Hypertension 56:901–906PubMedCrossRef
5.
Zurück zum Zitat Foster MC, Hwang S-J, Porter SA, Massaro JM, Hoffmann U, Fox CS (2011) Fatty kidney, hypertension, and chronic kidney disease: the Framingham Heart Study. Hypertension 58:784–790PubMedCrossRef Foster MC, Hwang S-J, Porter SA, Massaro JM, Hoffmann U, Fox CS (2011) Fatty kidney, hypertension, and chronic kidney disease: the Framingham Heart Study. Hypertension 58:784–790PubMedCrossRef
6.
Zurück zum Zitat Poortmans JR, Brauman H, Staroukine M, Verniory A, Decaestecker C, Leclercq R (1988) Indirect evidence of glomerular/tubular mixed-type postexercise proteinuria in healthy humans. Am J Physiol 254:F277–F283 (2 part 2)PubMed Poortmans JR, Brauman H, Staroukine M, Verniory A, Decaestecker C, Leclercq R (1988) Indirect evidence of glomerular/tubular mixed-type postexercise proteinuria in healthy humans. Am J Physiol 254:F277–F283 (2 part 2)PubMed
7.
Zurück zum Zitat Machann J, Thamer C, Schnoedt B et al (2005) Standardized assessment of whole body adipose tissue topography by MRI. J Magn Reson Imaging 21:455–462PubMedCrossRef Machann J, Thamer C, Schnoedt B et al (2005) Standardized assessment of whole body adipose tissue topography by MRI. J Magn Reson Imaging 21:455–462PubMedCrossRef
8.
Zurück zum Zitat Chatterjee TK, Stoll LL, Denning GM et al (2009) Proinflammatory phenotype of perivascular adipocytes: influence of high-fat feeding. Circ Res 104:541–549PubMedCrossRef Chatterjee TK, Stoll LL, Denning GM et al (2009) Proinflammatory phenotype of perivascular adipocytes: influence of high-fat feeding. Circ Res 104:541–549PubMedCrossRef
9.
Zurück zum Zitat Peter A, Weigert C, Staiger H et al (2009) Individual stearoyl-CoA desaturase 1 expression modulates endoplasmic reticulum stress and inflammation in human myotubes and is associated with skeletal muscle lipid storage and insulin sensitivity in vivo. Diabetes 58:1757–1765PubMedCrossRef Peter A, Weigert C, Staiger H et al (2009) Individual stearoyl-CoA desaturase 1 expression modulates endoplasmic reticulum stress and inflammation in human myotubes and is associated with skeletal muscle lipid storage and insulin sensitivity in vivo. Diabetes 58:1757–1765PubMedCrossRef
10.
Zurück zum Zitat Fornoni A (2010) Proteinuria, the podocyte, and insulin resistance. N Engl J Med 363:2068–2069PubMedCrossRef Fornoni A (2010) Proteinuria, the podocyte, and insulin resistance. N Engl J Med 363:2068–2069PubMedCrossRef
11.
Zurück zum Zitat Cesarini PR, Ferreira SR, Vivolo MA, Zanella MT (1996) Different urinary albumin responses to submaximal exercise by normoalbuminuric diabetic children and controls. Braz J Med Biol Res 29:1603–1610PubMed Cesarini PR, Ferreira SR, Vivolo MA, Zanella MT (1996) Different urinary albumin responses to submaximal exercise by normoalbuminuric diabetic children and controls. Braz J Med Biol Res 29:1603–1610PubMed
12.
Zurück zum Zitat Huttunen NP, Käär ML, Pietiläinen M, Vierikko P, Reinilä M (1981) Exercise-induced proteinuria in children and adolescents. Scand J Clin Lab Invest 41:583–587PubMedCrossRef Huttunen NP, Käär ML, Pietiläinen M, Vierikko P, Reinilä M (1981) Exercise-induced proteinuria in children and adolescents. Scand J Clin Lab Invest 41:583–587PubMedCrossRef
Metadaten
Titel
Exercise-induced albuminuria is associated with perivascular renal sinus fat in individuals at increased risk of type 2 diabetes
verfasst von
R. Wagner
J. Machann
R. Lehmann
K. Rittig
F. Schick
J. Lenhart
F. Artunc
K. Linder
C. D. Claussen
E. Schleicher
A. Fritsche
H.-U. Häring
P. Weyrich
Publikationsdatum
01.07.2012
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 7/2012
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-012-2551-z

Weitere Artikel der Ausgabe 7/2012

Diabetologia 7/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

NSCLC: Progressionsfreies Überleben unter Osimertinib fast versiebenfacht

06.06.2024 ASCO 2024 Kongressbericht

Erste Ergebnisse der Phase-III-Studie LAURA etablieren Osimertinib als neuen Therapiestandard für Menschen mit nicht-resezierbarem, EGFR-mutiertem, nicht-kleinzelligem Lungenkarzinom im Stadium III, die nach definitiver Radiochemotherapie progressionsfrei sind. Auf der ASCO-Tagung wurden diese beeindruckenden Ergebnisse besprochen.

Hodgkin Lymphom: BrECADD-Regime übertrifft die Erwartungen

05.06.2024 ASCO 2024 Kongressbericht

Das Kombinationsregime BrECADD mit Brentuximab vedotin ermöglichte in der Studie HD21 beim fortgeschrittenen klassischen Hodgkin-Lymphom eine unerwartet hohe progressionsfreie Überlebensrate von 94,3% nach vier Jahren. Gleichzeitig war das Regime besser tolerabel als der bisherige Standard eBEACOPP.

Antikörper-Drug-Konjugat verdoppelt PFS bei Multiplem Myelom

05.06.2024 ASCO 2024 Nachrichten

Zwei Phase-3-Studien deuten auf erhebliche Vorteile des Antikörper-Wirkstoff-Konjugats Belantamab-Mafodotin bei vorbehandelten Personen mit Multiplem Myelom: Im Vergleich mit einer Standard-Tripeltherapie wurde das progressionsfreie Überleben teilweise mehr als verdoppelt.

Neuer TKI gegen CML: Höhere Wirksamkeit, seltener Nebenwirkungen

05.06.2024 Chronische myeloische Leukämie Nachrichten

Der Tyrosinkinasehemmer (TKI) Asciminib ist älteren Vertretern dieser Gruppe bei CML offenbar überlegen: Personen mit frisch diagnostizierter CML entwickelten damit in einer Phase-3-Studie häufiger eine gute molekulare Response, aber seltener ernste Nebenwirkungen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.